The company intends to use the proceeds to accelerate the commercialization of its advanced energy surgical products for the operating room.
Led by President and CEO Scott Flora, OmniGuide is committed to developing advanced energy surgical instruments that enhance precision, and provide increased control in the field of minimally invasive surgery. Its BeamPath® flexible laser system has been used in over 40,000 adult and pediatric surgical procedures in the fields of Gynecology, ENT and Neurosurgery.
The company’s ﬁber products are based on proprietary technology invented at MIT and originally published in Science and Nature. It distributes them in the U.S. through a direct sales force and in Europe through distribution partners.